학술논문
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
Document Type
Erratum
Author
Source
In Annals of Oncology December 2019 30(12):2010-2010
Subject
Language
ISSN
0923-7534